Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × temsirolimus × 1 year × Clear all

Sponsor

Conditions

Neoplasms 4 Neoplasm Metastasis 3 Sarcoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Breast Neoplasms 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Soft Tissue Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Recurrence 1 Pharyngeal Neoplasms 1 PRETEXT I Hepatoblastoma 1 Neurofibromatosis 2 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Mesothelial 1 Mouth Neoplasms 1 Melanoma 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Erdheim-Chester Disease 1 Endometrial Adenocarcinoma 1 Endocrine Gland Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1

Interventions

Cyclophosphamide 11 Prednisone 8 Doxorubicin 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Vincristine 6 Azacitidine 5 fludarabine 4 Gemcitabine 4 Etoposide 4 Brentuximab Vedotin 4 romidepsin 3 belinostat 3 Dexamethasone 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 selinexor 1 relatlimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡